Clinical trial
Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating…
NCT00068523 · Case Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00068523 |
|---|---|
| Title | Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies |
| Official title | Immunomodulation by Ultraviolet B-Irradiation (UVB) to Facilitate Allogeneic Stem Cell Transplantation for Treatment of Hematologic Malignancies |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases |
| Intervention type | Biological, Drug, Procedure |
| Interventions | anti-thymocyte globulin, cyclophosphamide, cyclosporine, fludarabine phosphate, methylprednisolone, UV light therapy, allogeneic bone marrow transplantation, peripheral blood stem cell transplantation |
| Enrollment | 10 |
| Start date | Jun 1, 2003 |
| Primary completion | Mar 1, 2004 |
| First posted | Sep 11, 2003 |
| Last update posted | Jul 27, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: